SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-25648
Recombinant Monoclonal Antibody
Key Product Details
Species Reactivity
SARS-CoV-2
Applications
Immunocytochemistry/ Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # HL1088
Format
Azide and BSA Free
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Carrier-protein conjugated synthetic peptide encompassing a sequence within the C-terminus region of SARS-CoV-2 Membrane Protein. The exact sequence is proprietary.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free
Immunocytochemistry/Immunofluorescence: SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free [NBP3-25648] -
Immunocytochemistry/Immunofluorescence: SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free [NBP3-25648] - SARS-CoV-2 (COVID-19) Membrane antibody [HL1088] detects SARS-CoV-2 (COVID-19) Membrane protein by immunofluorescent analysis. Sample: 293T cells were fixed in 4% paraformaldehyde at RT for 15 min. Green: SARS-CoV-2 (COVID-19) Membrane stained by SARS-CoV-2 (COVID-19) Membrane antibody [HL1088] (NBP3-25648) diluted at 1:2000. Blue: Fluoroshield with DAPI .Western Blot: SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free [NBP3-25648] -
Western Blot: SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free [NBP3-25648] - Non-transfected (-) and transfected (+) 293T whole cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with SARS-CoV-2 (COVID-19) Membrane antibody [HL1088] (NBP3-25648) diluted at 1:20000. The HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody.Applications for SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free
Application
Recommended Usage
Immunocytochemistry/ Immunofluorescence
1:100-1:2000
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Format
Azide and BSA Free
Preservative
No Preservative
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: SARS-CoV-2 Membrane Protein
References
1. Malik Y. A. (2020). Properties of Coronavirus and SARS-CoV-2. The Malaysian Journal of Pathology.
2. Yoshimoto F. K. (2020). The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or n-COV19), the Cause of COVID-19. The Protein Journal. https://doi.org/10.1007/s10930-020-09901-4
3. Uniprot (P0DTC5)
4. J Alsaadi, E. A., & Jones, I. M. (2019). Membrane binding proteins of coronaviruses. Future Virology. https://doi.org/10.2217/fvl-2018-0144
Alternate Names
2019-nCoV M protein, 2019-nCoV Membrane Protein, COVID-19 E1 Glycoprotein, COVID-19 Matrix glycoprotein, COVID-19 Membrane, COVID-19 Membrane glycoprotein, E1 glycoprotein, Human coronavirus Membrane Protein, Matrix glycoprotein, Membrane glycoprotein, Membrane Protein, SARS-CoV-2, SARS-CoV-2 E1 Glycoprotein, SARS-CoV-2 M Protein, SARS-CoV-2 Matrix glycoprotein, SARS-CoV-2 Membrane glycoprotein, SARSCoV2 Membrane Protein, Severe Acute Respiratory Syndrome Coronavirus 2
Gene Symbol
M
Additional SARS-CoV-2 Membrane Protein Products
Product Documents for SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free
Product Specific Notices for SARS-CoV-2 Membrane Protein Antibody (HL1088) - Azide and BSA Free
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...